Mizuho Securities USA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.86M Buy
100,514
+23,011
+30% +$1.86M 0.13% 138
2026
Q1
$6.72M Sell
77,503
-15,889
-17% -$1.52M 0.16% 133
2025
Q4
$9.84M Buy
93,392
+73
+0.1% +$7.09K 0.16% 107
2025
Q3
$8.66M Buy
93,319
+4,681
+5% +$430K 0.18% 113
2025
Q2
$7.73M Sell
88,638
-14,034
-14% -$1.19M 0.16% 118
2025
Q1
$9.23M Sell
102,672
-18,877
-16% -$1.69M 0.2% 102
2024
Q4
$9.71M Buy
121,549
+38,379
+46% +$3.32M 0.18% 107
2024
Q3
$7.49M Sell
83,170
-19,214
-19% -$1.62M 0.16% 103
2024
Q2
$8.06M Buy
+102,384
New +$8.39M 0.18% 104
2020
Q3
Sell
-2,701
Closed -$248K 182
2020
Q2
$248K Buy
+2,701
New +$259K 0.02% 125

Other funds holding MDT

Mizuho Securities USA's MDT Position: Q2 2026 in Review

Mizuho Securities USA increased its Medtronic (MDT) stake by 30% in Q2 2026, buying an estimated $1.86M and bringing the position to 100,514 shares worth $7.86M. The position accounts for 0.13% of the portfolio, ranked #138.

Mizuho Securities USA first reported a position in MDT in Q2 2020 and has held it in 10 quarters since. The position peaked at $9.84M in Q4 2025. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mizuho Securities USA held 100,514 shares of Medtronic worth $7.86M as of Q2 2026.
  • Mizuho Securities USA bought 23,011 Medtronic shares in Q2 2026, an estimated $1.86M.
  • Medtronic made up 0.13% of Mizuho Securities USA's portfolio in Q2 2026, its #138 holding.
  • Mizuho Securities USA first reported a position in Medtronic in Q2 2020 and has held it in 10 quarters since.
  • Mizuho Securities USA's Medtronic position peaked at $9.84M in Q4 2025.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.